A microfluidic paper-based analytical device for the assay of albumin-corrected fructosamine values from whole blood samples
- 31 December 2014
- journal article
- research article
- Published by Taylor & Francis in Bioanalysis
- Vol. 7 (1) , 79-90
Abstract
Background: A method for acquiring albumin-corrected fructosamine values from whole blood using a microfluidic paper-based analytical system that offers substantial improvement over previous methods is proposed. Results: The time required to quantify both serum albumin and fructosamine is shortened to 10 min with detection limits of 0.50 g dl(-1) and 0.58 mM, respectively (S/N = 3). The proposed system also exhibited good within-run and run-to-run reproducibility. The results of the interference study revealed that the acceptable recoveries ranged from 95.1 to 106.2%. The system was compared with currently used large-scale methods (n = 15), and the results demonstrated good agreement among the techniques. Conclusion: The microfluidic paper-based system has the potential to continuously monitor glycemic levels in low resource settings.Keywords
Funding Information
- Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University ((RES 560530212-HR))
This publication has 32 references indexed in Scilit:
- Serum Fructosamine and Glycated Albumin and Risk of Mortality and Clinical Outcomes in Hemodialysis PatientsDiabetes Care, 2013
- The USRDSClinical Journal of the American Society of Nephrology, 2013
- US Renal Data System 2011 Annual Data ReportAmerican Journal of Kidney Diseases, 2012
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patientsKidney International, 2010
- Hemoglobin A1c and Fructosamine for Assessing Glycemic Control in Diabetic Patients With CKD Stages 3 and 4American Journal of Kidney Diseases, 2010
- Tests of Glycemia in DiabetesDiabetes Care, 2004
- Diabetes education and care management significantly improve patient outcomes in the dialysis unitAmerican Journal of Kidney Diseases, 2002
- Progression of diabetic nephropathyKidney International, 2001
- Serum Glycated Albumin and Fructosamine in Renal Dialysis PatientsNephron, 1993